Market Insights Snapshot
Looking at the performance of the cannabis brand Pure Ratios in the Topical category within Washington state, there has been a notable fluctuation in their ranking over the past few months. In June 2023, they were ranked 17th, moved up to 15th place by August, but then slipped back down to 19th place by September. This movement indicates a struggle to maintain a consistent position within the top 20 brands in this category and state. It's worth noting that a lack of ranking for a particular month signifies that they did not make it into the top 20, which is a point of concern.
When we examine the sales data, there is a clear downward trend in the sales of Pure Ratios. In August 2023, they recorded sales of $3195 but by September, this figure had drastically reduced to $1097. This sharp decrease in sales is likely connected to their drop in ranking. It's crucial for brands like Pure Ratios to understand these trends and adapt their strategies accordingly to ensure they consistently rank within the top brands and maintain healthy sales figures. This data provides a glimpse into the competitive landscape of the Topical cannabis market in Washington state.
In the Topical category for the state of Washington, Pure Ratios has seen a fluctuation in its rank over the months of June to September 2023, moving from 17th to 15th, then dropping to 19th. This indicates a level of volatility in its market position. Compared to its competitors, Pure Ratios has consistently ranked higher than Verdelux and Heylo, but has been outperformed by Flex-All in July and June. The brand INDO was not in the top 20 in June, indicating a lower market presence. In terms of sales, Pure Ratios has seen a downward trend from June to September, which could be a cause for concern. However, it's worth noting that despite the rank fluctuations, Pure Ratios has consistently outperformed its competitors in sales, indicating a strong customer base.
In September 2023, Pure Ratios' top-performing product was the CBD/THC 18:1 Transdermal Reservoir Patch (36mg CBD, 2mg THC), maintaining its top position from the previous two months. It sold 26 units, a decline from 99 units in August. The second best-selling product was the CBD/THC 18:1 Transdermal Reservoir Patch (38mg CBD, 2mg THC), moving up from the fifth position in August. The CBD/THC 4:1 Transdermal Reservoir Patch (32mg CBD, 8mg THC) held the third spot, consistent with its ranking in August. The CBD:THC 4:1 Patch (32mg CBD, 8mg THC) climbed from unranked to the fourth position in September.